TELA Bio, Inc.
TELANasdaqCIK 1561921HealthcareFiscal year ends Dec 31
Reports and events: 151 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0820:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-114695 |
| 2026-10-0620:05 ET | 8-K | 8.01 Other events | 0001104659-26-114042 |
| 2026-10-0512:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-113506 |
| 2026-09-2920:05 ET | 8-K | 1.01 Entry into a material agreement | 0001104659-26-111920 |
| 2026-09-1820:05 ET | 8-K | 3.01 Delisting notice | 0001104659-26-108935 |
| 2026-09-1420:05 ET | DEF 14A | Proxy statementPeriod 2026-10-08 | 0001104659-26-107491 |
| 2026-08-3111:05 ET | 8-K | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-103548 |
| 2026-08-1320:05 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001104659-26-095892 |
| 2026-08-1120:05 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-094039 |
| 2026-08-1020:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-093371 |
| 2026-08-0411:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-26-090056 |
| 2026-06-1120:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-072931 |
| 2026-06-0922:29 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-264406 |
| 2026-05-1320:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-060234 |
| 2026-05-1220:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-059393 |
| 2026-04-3021:00 ET | DEF 14A | Proxy statementPeriod 2026-06-09 | 0001104659-26-053117 |
| 2026-04-3020:57 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001104659-26-053102 |
| 2026-03-2520:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-034507 |
| 2026-03-2420:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-033839 |
| 2026-03-2020:05 ET | 8-K | 3.01 Delisting notice | 0001104659-26-032697 |
| 2025-11-1421:38 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-25-112653 |
| 2025-11-1421:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-112476 |
| 2025-11-1321:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-111285 |
| 2025-11-0321:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-105548 |
| 2025-10-0920:12 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-25-098354 |
| 2025-08-1120:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001558370-25-011052 |
| 2025-08-1120:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-076153 |
| 2025-06-0212:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-055248 |
| 2025-05-3020:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001104659-25-054867 |
| 2025-05-0820:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001558370-25-006994 |
| 2025-05-0820:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-046124 |
| 2025-04-1720:16 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0001104659-25-036020 |
| 2025-03-3111:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-029612 |
| 2025-03-2120:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001558370-25-003460 |
| 2025-03-2020:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-026142 |
| 2024-11-0821:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001558370-24-015050 |
| 2024-11-0721:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-115317 |
| 2024-10-2520:24 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000823 |
| 2024-10-2321:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-110891 |
| 2024-10-2220:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001104659-24-110552 |
| 2024-10-0121:35 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000783 |
| 2024-08-1320:20 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001558370-24-012060 |
| 2024-08-1220:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-088353 |
| 2024-07-0220:58 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000584 |
| 2024-06-0620:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-069099 |
| 2024-05-2020:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-063416 |
| 2024-05-1020:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007784 |
| 2024-05-0920:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-059355 |
| 2024-04-1820:06 ET | DEF 14A | Proxy statementPeriod 2024-06-04 | 0001104659-24-048835 |
| 2024-04-1511:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-046970 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.